Cohance Lifesciences
Dr. Prasada Raju. V is an accomplished pharmaceutical professional with extensive experience in leadership roles. Currently serving as Managing Director at Suven Pharmaceuticals Ltd and Cohance Lifesciences, Dr. Raju has previously held significant positions, including Executive Director at Granules India Limited and Pharmaceutical Professional in the healthcare sector. Dr. Raju's academic credentials include a PhD in Chemistry from JNTUH College of Engineering Hyderabad and a Senior Management Programme focused on Mergers and Acquisitions & Corporate Strategy from the Indian Institute of Management, Calcutta.
Cohance Lifesciences
Cohance Lifesciences is a global, merchant API platform. With 8 manufacturing units (including 5 USFDA approved units) and 2 R&D dedicated units, we serve our marquee clients as partner of choice in a range of niche Intermediates, API, Pharmaceutical Formulation intermediates (PFI), Formulations & Speciality chemicals across both Innovator and Generic molecules. We also specialise in highly specialised CRAMS and Clinical research. As a global player, we have presence in 60 countries and have a growing product basket of 80+ molecules backed by robust R&D and Infrastructure.